From December 2 to 3, Yang Sheng, a member of the party group and deputy director of the State Drug Administration, attended a special work conference on the high-quality development of traditional Chinese medicine and ethnic medicine in the western region in Xining, Qinghai, and visited ethnic pharmaceutical companies and Tibetan hospitals for research. Yang Sheng stressed that it is necessary to thoroughly implement the spirit of the Fourth Plenary Session of the 20th CPC Central Committee, meet the requirements of the “15th Five-Year Plan” with high-quality development as the theme and reform and innovation as the fundamental driving force, form regional synergy, accelerate the upgrading of national medicine standards and establish a solid foundation for development; give full play to local advantages, make full use of support policies, and promote innovation and transformation of specialty ethnic medicines and medical institution formulations; adhere to integrated development and safety, strengthen territorial supervision and regional collaboration, and push the high-quality development of the ethnic pharmaceutical industry to a new level.

From December 2 to 3, Yang Sheng, a member of the party group and deputy director of the State Drug Administration, attended a special work conference on the high-quality development of traditional Chinese medicine and ethnic medicine in the western region in Xining, Qinghai, and visited ethnic pharmaceutical companies and Tibetan hospitals for research. Yang Sheng stressed that it is necessary to thoroughly implement the spirit of the Fourth Plenary Session of the 20th CPC Central Committee, meet the requirements of the “15th Five-Year Plan” with high-quality development as the theme and reform and innovation as the fundamental driving force, form regional synergy, accelerate the upgrading of national medicine standards and establish a solid foundation for development; give full play to local advantages, make full use of support policies, and promote innovation and transformation of specialty ethnic medicines and medical institution formulations; adhere to integrated development and safety, strengthen territorial supervision and regional collaboration, and push the high-quality development of the ethnic pharmaceutical industry to a new level.